Skip to main content
HR 2518 112th Congress House

To extend for 5 years the authorization of appropriations for the sickle cell disease prevention and treatment demonstration program.

Introduced: October 26, 2011 Introduced by: Davis, Danny K. Democratic · Illinois See on congress.gov
Health Blood and blood diseasesHealth programs administration and fundingHealth promotion and preventive careHereditary and development disorders
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 15, 2011
Referred to the Subcommittee on Health.
Jul 13, 2011
Referred to the House Committee on Energy and Commerce.
Jul 13, 2011
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 15, 2011

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Amends the American Jobs Creation Act of 2004 to reauthorize appropriations for FY2013-FY2017 for a demonstration program to develop and establish systemic mechanisms to improve the prevention and treatment of Sickle Cell Disease.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 3
All 3 Democratic 1
D
Bishop, Sanford D.
Georgia · Oct 26, 2011
VISCLOSKY, PETER
· Oct 3, 2011
SHIMKUS, JOHN
· Jul 13, 2011
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2518: To extend for 5 years the authorization of appropriations for the sickle cell disease prevention and treatment demonstration program.. 112th Congress. Open America. https://openamerica.io/bill/112-HR-2518/
MLA
"H.R. 2518: To extend for 5 years the authorization of appropriations for the sickle cell disease prevention and treatment demonstration program.." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-2518/.
Bluebook (legal)
H.R. 2518, 112th Cong. (2026), https://openamerica.io/bill/112-HR-2518/.
Markdown link
[H.R. 2518: To extend for 5 years the authorization of appropriations for the sickle cell disease prevention and treatment demonstration program.](https://openamerica.io/bill/112-HR-2518/)
Report a problem